Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4c040d36ba60026b08b2709734d4b0f9 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-552 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5252 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-24034 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55561 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-521 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-24134 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-24161 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-24122 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12 |
filingDate |
2006-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2011-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8dcc18a745e256def8abdd6748fbebc5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27d7caa6090f3b00a7b6f2aa2e27af81 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4668ec0caec211884067d422a624712c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8de74e1dd5fd1e57fb025537ccde358 |
publicationDate |
2011-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
RU-2436591-C2 |
titleOfInvention |
Inactivated chimeric vaccines and related methods of application |
abstract |
FIELD: medicine. ^ SUBSTANCE: group of inventions refers to veterinary science, and concerns inactivated chimeric vaccines and related methods of application. Substance of the inventions involves an inactivated chimeric flavivirus containing a first flavivirus representing a yellow fever virus in which nucleotide sequences coding pre-membrane and membrane proteins are substituted by nucleotide sequences coding pre-membrane and membrane proteins a second flavivirus representing a West Nile fever virus. The inventions also involve an immunogenic composition and a vaccine for protection of animals from the flavivirus infections, involving the inactivated chimeric flavivirus. ^ EFFECT: development of the advanced immunogenic composition and the vaccine on the basis of the inactivated chimeric flavivirus. ^ 14 cl, 3 ex, 5 tbl |
priorityDate |
2005-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |